Research Library — Peptide Longevity Q&A — Page 16 | Reta Compare
640 research articles in Peptide Longevity Q&A. Page 16 of 26.
Articles
- What does research show about LL-37 for oral health and disease?
- How does LL-37 enhance antimicrobial activity in aging stem cells?
- How does LL-37 influence neuroinflammation related to Alzheimer's disease?
- How does LL-37 enhance antibacterial activity during fever?
- How does LL-37 contribute to tissue regeneration and wound repair with age?
- How does LL-37 relate to chronic lung diseases and aging?
- Does LL-37 inhibit inflammation to support longevity in aging individuals?
- Does LL-37 reduce inflammaging in older adults?
- Can LL-37 influence immune evasion in breast cancer metastasis?
- How does LL-37 influence neuroinflammation in aging and neurodegeneration?
- How does LL-37 contribute to the progression of idiopathic interstitial pneumonia?
- Does LL-37 enhance resistance to antimicrobial peptides in aging organisms?
- What does research show about LL-37 for periodontal therapy and longevity?
- Can LL-37 serve as a biomarker for periodontal healing in aging populations?
- Can MOTS-c protect against neurotoxicity in aging neurons?
- What does research show about MOTS-c in adolescents with PCOS?
- How does MOTS-c promote mitophagy in cardiac dysfunction after high altitude exposure?
- How does MOTS-c protect spermatogenesis in aging males?
- How does MOTS-c support cellular longevity in oxidative stress conditions?
- Can MOTS-c improve mitochondrial function in retinal degeneration models?
- Can MOTS-c enhance mitochondrial protection against oxidative stress in aging?
- Can MOTS-c improve mitochondrial function in aging muscle tissue?
- How does MOTS-c influence metabolic health in aging lambs?
- Does MOTS-c reduce inflammaging in older adults?
- Can MOTS-c protect against acetaminophen-induced liver injury in aging?